Career Development Program

职业发展计划

基本信息

批准号：
8380924
负责人：
ELIZABETH A GRIMM
金额：
$ 7.9万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
起止时间：
2004-07-09 至
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/8380924
关键词：
Academic Training Advisory Committees Area Award Basic Science Behavioral Biochemistry Bioethics Biological Biology Budgets Cancer Biology Clinical Clinical Investigator Clinical Research Clinical trial protocol document Commit Cutaneous Melanoma Data Decision Making Doctor of Medicine Doctor of Philosophy Educational Status Educational process of instructing Environment Etiology Faculty Fellowship Funding Future Genetic Predisposition to Disease Goals Grant Heterogeneity Human Human Genetics Immunology Individual Interdisciplinary Study Intervention K-Series Research Career Programs Knowledge Laboratories Laboratory Scientists Learning Mentors Mentorship Metastatic Melanoma Molecular Molecular Biology Neoplasm Metastasis Patients Persons Physicians Postdoctoral Fellow Process Publications Qualifying Recruitment Activity Research Research Personnel Scientist Senior Scientist Skin Cancer Training Translational Research University of Texas M D Anderson Cancer Center Work base career development design experience high standard improved innovation meetings melanoma member professor programs success

项目摘要

The goal pf the Melanoma SPORE Career Development Program (CDP) is to develop an integrated cadre of investigators at all levels of training dedicated to translational research on human melanoma. We have successfully accomplished this goal over the past 4.5 years of this SPORE through our funding and training of ten CDP recipients who are now supporting their melanoma research through 1 R01,1 CIDR, 2 R21s, and one MDACC Institutional grant on melanoma. In addition they have generated a substantial quantity of new data and information resulting in 20 publications. We will continue this program and aim to (1) recruit junior and senior physicians and basic laboratory scientists and support them to become competent translational investigators in the study of melanoma, (2) provide in-depth training in translational science principles of human cancer biology not commonly included in clinical fellowship training or Ph.D. programs, and (3) teach the fundamentals of the biology and clinical course of human melanoma to improve the ability of the awardees to conduct innovative translational research. The unique educational environment at M.D. Anderson and in the M.D. Anderson Melanoma Multidisciplinary Research Program has and will continue to assure that these goals are met. Up to three career development trainees (preferably 2 faculty members and 1 post doctoral fellow) will be supported annually. A portion of the NCl SPORE budget ($75,000 per year) plus half of the institutional commitment funds ($100,000 for the CDP per year) provided by the M.D. Anderson is available to the SPORE, resulting in $175,000 each year to Support the CDP in Melanoma. Solicitations will be made yeariy for qualified candidates from within and outside of M.D. Anderson. The awardees will be reviewed and ranked by the SPORE Executive Committee and Internal Advisory Committee, with final decision made by the External Advisory Committee. A second year of support will also be available contingent upon review by the Internal Advisory Committee. Our mentorship program includes nationally recognized clinical and translational investigators who provide comprehensive training. Their success is evident in the accomplishments of the group of scientists awarded CDP awards over the last 4.5 year. Two of these individuals are now full contributors of this SPORE serving as Co-Leaders of projects. We propose to continue the high standards we have established and evaluate our program annually. We will modify our selection and training processes as required allowing us to continue to train future scientist in translational research on human melanoma throughout the term of this SPORE.

黑色素瘤 SPORE 职业发展计划 (CDP) 的目标是培养一支经过各级培训的综合研究人员队伍，致力于人类黑色素瘤的转化研究。在过去 4.5 年的 SPORE 中，我们通过资助和培训 10 名 CDP 接受者成功实现了这一目标，他们现在通过 1 R01、1 CIDR、2 R21s、以及一项关于黑色素瘤的 MDACC 机构拨款。此外，他们还生成了大量新数据和信息，并出版了 20 种出版物。我们将继续该计划，目标是（1）招募初级和高级医生以及基础实验室科学家，并支持他们成为黑色素瘤研究领域的合格转化研究者，（2）提供转化科学方面的深入培训人类癌症生物学原理通常不包含在临床研究员培训或博士学位中。项目，（3）教授人类黑色素瘤的生物学基础知识和临床课程，以提高获奖者进行创新转化研究的能力。 M.D. 独特的教育环境安德森和MD安德森黑色素瘤多学科研究计划已经并将继续确保实现这些目标。每年最多将支持三名职业发展培训生（最好是 2 名教员和 1 名博士后）。 NCl SPORE 预算的一部分（每年 75,000 美元）再加上 M.D. Anderson 提供的一半机构承诺资金（每年为 CDP 提供 100,000 美元）可供 SPORE 使用，这样每年就有 175,000 美元用于支持 CDP 的黑色素瘤治疗。每年都会向 M.D. Anderson 内部和外部的合格候选人进行征集。获奖者将由SPORE执行委员会和内部顾问委员会进行审核和排名，并由外部顾问委员会做出最终决定。根据内部咨询委员会的审查，还将提供第二年的支持。我们的辅导计划包括国家认可的临床和转化研究人员提供全面的培训。他们的成功从过去 4.5 年荣获 CDP 奖项的科学家团队所取得的成就中可见一斑。其中两人现在是该 SPORE 的完全贡献者，担任项目的联合领导者。我们建议继续保持已建立的高标准，并每年评估我们的计划。我们将根据需要修改我们的选择和培训流程，使我们能够在整个 SPORE 期间继续培训未来的科学家进行人类黑色素瘤的转化研究。